期刊文献+

67例甲磺酸加贝酯不良反应报告分析

Analysis of adverse reactions of gabexate mesylate in 67 cases
下载PDF
导出
摘要 目的探讨甲磺酸加贝酯导致不良反应(ADR)的一般规律和特点,为临床合理用药提供参考。方法从两家医院药品不良反应监测管理系统中调取2014年1月~2019年3月填报的甲磺酸加贝酯相关ADR报告共67例,通过回顾性统计法对ADR报告进行综合分析。结果67例ADR患者中,男女发生率差异无统计学意义,年龄>60岁的ADR发生率累计超过50%,多在用药30 min内发生,主要累及器官/系统:皮肤黏膜(78.38%)、循环系统(13.52%)、消化系统(4.05%)、中枢神经系统(4.05%),主要临床表现为皮疹、瘙痒、输注部位红肿疼痛、心慌、胸闷、潮红、血压下降、口干、恶心、呕吐等。结论需重视甲磺酸加贝酯引起的不良反应,加强临床用药指导,确保用药安全。 Objective To explore the general rules and characteristics of adverse reactions(ADR)caused by gabeste mesylate,and to provide a reference for clinical rational drug use.Methods A total of 67 ADR reports related to gabecyl mesylate reported from January 2014 to March 2019 were collected from the ADR monitoring and management system of two hospitals.A retrospective statistical method was used to comprehensively analyze the ADR report.Results Among the 67 patients with ADR,there was no significant difference between women and men.The incidence of ADR over 60 years of age was accumulated more than 50%,and most of them occurred within 30 minutes of medication.The main organs/systems were involved:skin and mucosa(78.38%),circulatory system(13.52%),digestive system(4.05%),central nervous system(4.05%).The main clinical manifestations are rash,itching,redness,swelling and pain at the infusion site,palpitation,chest tightness,flushing,decreased blood pressure,dry mouth,nausea,avomiting and so on.Conclusion It is important to pay attention to the adverse reactions caused by gabexate mesylate,strengthen clinical rational use of drugs,in order to ensure the safe drug use in clinic.
作者 钱娜 姚东 苟小军 沈伟 QIAN Na;YAO Dong;GOU Xiao-jun(Jingjiang Hospital of Traditional Chinese Medicine,Jingjiang 214500,China)
出处 《中国处方药》 2021年第7期70-72,共3页 Journal of China Prescription Drug
基金 宝山区中西医结合医院院级基金(201610)。
关键词 甲磺酸加贝酯 不良反应 监测 分析 Gabexate Mesylate Adverse reactions Monitoring Analysis
  • 相关文献

参考文献10

二级参考文献56

  • 1吴叔明,徐华,戈之铮,莫剑忠,陈胜良,杨川华.加贝酯对Oddi括约肌运动的影响[J].中华消化杂志,2004,24(8):464-467. 被引量:26
  • 2彭国林,李兆申.加贝酯防治急性胰腺炎应用现状[J].胰腺病学,2005,5(3):177-179. 被引量:15
  • 3Aliperti G. Complications related to diagnostic and therapeutic endoscopic retrograde cholangiopancreatography. Gastrointest Endosc Clin North Am, 1996,6: 379-407.
  • 4Chen YK, Foliente RL, Santoro MJ, et al. Endoscopic sphincterotomy-induced pancreatitis: Increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol ,1994,89: 327-333.
  • 5Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med, 1996, 335:919-923.
  • 6Matsumura T, Yada S, Miyoshi Y, et al. Effect of synthetic protease inhibitor on the sphincter of Oddi function in dogs. Nippon Shokakibyo Gakkai Zasshi, 1991, 88:2663-2670.
  • 7Di Francesco V, Marriani A, Angelini G , et al. Effects of gabexate mesilate,a protease inhibitor, on human sphincter of Oddi motility.Dig Dis Sci, 2002, 47:741-745.
  • 8Vincenzo Di Francesco,Alberto Mariani,Giampaolo Angelini,Enzo Masci,Luca Frulloni,Giorgio Talamini,Sandro Passaretti,Pieralberto Testoni,Giorgio Cavallini. Effects of Gabexate Mesilate, a Protease Inhibitor, on Human Sphincter of Oddi Motility[J] 2002,Digestive Diseases and Sciences(4):741~745
  • 9叶任高;陆再英.内科学[M]北京:人民卫生出版社,2005466.
  • 10马家骥.内科学[M]北京:人民卫生出版社,2006283.

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部